FAH and Tyrosinemia type 1: Furthermore, in a murine model of tyrosinemia type I simulated by insertion of a neomycin cassette (1378 bp) in the Fah gene, PEDAR was able to restore FAH expression in ~0.76% of hepatocytes one week after administration of a plasmid based PEDAR system.